N1 Life

We are a respected global company with laboratories and teams located in the United States, China, and other countries. Human imagination and innovation—coupled with new technology—are shaping an industry through innovative ways to treat aggressive diseases. N1 Life’s fearless pursuit of drug delivery technologies—using science as the solution—leads the way to overcome traditional drug development’s high failure rate because of human tissue complexities. With tissue as the issue, our new technologies are paving the way for life-changing treatment opportunities for people experiencing severe and untreatable diseases. N1 Life is a pioneering company in the field of drug delivery technology. Our new technology platforms, AbsotrideTM Peptide-based Delivery Platform, and ChARLSTM Polymer-based Delivery Platform enable better drug discovery and development. N1 Life is a biotech company that originated as a Stanford University spinout start-up to develop innovative tissue-focused drug delivery technologies for new therapeutics to address unmet medical needs. N1 Life was cofounded by Stanford professor Dr.